Scholarlink

<p>Testing drug powders before consumption is a harm reduction measure that could help prevent accidental overdoses. Fentanyl test strips (FTS) are used to test for fentanyl in powders, but comprehensive, comparative data assessing commercial test strips’ performance is currently unavailable. To address this gap, we analyzed drug powders using FTS from three different vendors using the manufacturer’s recommended testing procedures. Each FTS was assessed for sensitivity to fentanyl, cross-reactivity with fentanyl analogs, and selectivity by testing other relevant compounds. None of the FTS was as sensitive as claimed by the manufacturer nor could they detect all fentanyl analogs tested, which were selected based on their recent prevalence. The drugs responsible for the most false positives were stimulants, hallucinogens, synthetic opioids, and the cutting agent, diphenhydramine. Overall, testing of DanceSafe FTS resulted in the highest sensitivity for fentanyl, the highest selectivity when tested with other substances (fewest false positives), and moderate cross-reactivity with analogs. Testing of BTNX FTS resulted in the highest cross-reactivity with fentanyl analogs and moderate sensitivity for fentanyl. These results provide valuable information when selecting FTS for harm reduction as well as understanding the implications of each test’s results. While no FTS tested performed as marketed, they still remain valuable as drug checking or screening tools to prevent drug overdose deaths.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Assessment of Test Strips for Detection of Fentanyl in Powders

  • 期刊论文

  • 发表日期：

    2026年5月22日

查看全文
  • Jessica L. Armstrong,
  • Rebekah E. Wharton

摘要

Testing drug powders before consumption is a harm reduction measure that could help prevent accidental overdoses. Fentanyl test strips (FTS) are used to test for fentanyl in powders, but comprehensive, comparative data assessing commercial test strips’ performance is currently unavailable. To address this gap, we analyzed drug powders using FTS from three different vendors using the manufacturer’s recommended testing procedures. Each FTS was assessed for sensitivity to fentanyl, cross-reactivity with fentanyl analogs, and selectivity by testing other relevant compounds. None of the FTS was as sensitive as claimed by the manufacturer nor could they detect all fentanyl analogs tested, which were selected based on their recent prevalence. The drugs responsible for the most false positives were stimulants, hallucinogens, synthetic opioids, and the cutting agent, diphenhydramine. Overall, testing of DanceSafe FTS resulted in the highest sensitivity for fentanyl, the highest selectivity when tested with other substances (fewest false positives), and moderate cross-reactivity with analogs. Testing of BTNX FTS resulted in the highest cross-reactivity with fentanyl analogs and moderate sensitivity for fentanyl. These results provide valuable information when selecting FTS for harm reduction as well as understanding the implications of each test’s results. While no FTS tested performed as marketed, they still remain valuable as drug checking or screening tools to prevent drug overdose deaths.